Patient preferences for HIV service delivery models; a Discrete Choice Experiment in Kisumu, Kenya.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2022
Historique:
received: 15 12 2021
accepted: 26 09 2022
entrez: 24 3 2023
pubmed: 25 3 2023
medline: 25 3 2023
Statut: epublish

Résumé

Novel "differentiated service delivery" models for HIV treatment that reduce clinic visit frequency, minimize waiting time, and deliver treatment in the community promise retention improvement for HIV treatment in Sub-Saharan Africa. Quantitative assessments of differentiated service delivery (DSD) feature most preferred by patient populations do not widely exist but could inform selection and prioritization of different DSD models. We used a discrete choice experiment (DCE) to elicit patient preferences of HIV treatment services and how they differ across DSD models. We surveyed 18+year-olds, enrolled in HIV care for ≥6 months between February-March, 2019 at four facilities in Kisumu County, Kenya. DCE offered patients a series of comparisons between three treatment models, each varying across seven attributes: ART refill location, quantity of dispensed ART at each refill, medication pick-up hours, type of adherence support, clinical visit frequency, staff attitude, and professional cadre of person providing ART refills. We used hierarchical Bayesian model to estimate attribute importance and relative desirability of care characteristics, latent class analysis (LCA) for groups of preferences and mixed logit model for willingness to trade analysis. Of 242 patients, 128 (53.8%) were females and 150 (62.8%) lived in rural areas. Patients placed greatest importance on ART refill location [19.5% (95% CI 18.4, 10.6) and adherence support [19.5% (95% CI 18.17, 20.3)], followed by staff attitude [16.1% (95% CI 15.1, 17.2)]. In the mixed logit, patients preferred nice attitude of staff (coefficient = 1.60), refill ART health center (Coeff = 1.58) and individual adherence support (Coeff = 1.54), 3 or 6 months for ART refill (Coeff = 0.95 and 0.80, respectively) and pharmacists (instead of lay health workers) providing ART refill (Coeff = 0.64). No differences were observed by gender or urbanicity. LCA revealed two distinct groups (59.5% vs. 40.5%). Participants preferred 3 to 6-month refill interval or clinic visit spacing, which DSD offers stable patients. While DSD has encouraged community ART group options, our results suggest strong preferences for ART refills from health-centers or pharmacists over lay-caregivers or community members. These preferences held across gender&urban/rural subpopulations.

Identifiants

pubmed: 36962597
doi: 10.1371/journal.pgph.0000614
pii: PGPH-D-21-01122
pmc: PMC10021384
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0000614

Informations de copyright

Copyright: © 2022 Mando et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Health Policy Plan. 2009 Mar;24(2):151-8
pubmed: 19112071
AIDS Patient Care STDS. 2012 Jan;26(1):20-8
pubmed: 22149903
AIDS Behav. 2010 Aug;14(4):807-15
pubmed: 19533322
Public Health. 2019 Feb;167:50-54
pubmed: 30639803
Curr Opin HIV AIDS. 2019 Jan;14(1):60-65
pubmed: 30394947
AIDS Behav. 2021 Feb;25(2):397-413
pubmed: 32812124
PLoS One. 2020 Jan 28;15(1):e0228148
pubmed: 31990930
PLoS Med. 2019 Jul 23;16(7):e1002874
pubmed: 31335865
Ann Pharmacother. 2009 Jun;43(6):1036-44
pubmed: 19491319
PLoS One. 2021 Aug 25;16(8):e0255650
pubmed: 34432795
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21647
pubmed: 28770599
BMC Health Serv Res. 2019 Feb 4;19(1):95
pubmed: 30717715
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21650
pubmed: 28770594
J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):e58-60
pubmed: 24378724
PLoS One. 2018 Jan 10;13(1):e0190286
pubmed: 29320531
Int J STD AIDS. 2014 Feb;25(2):105-12
pubmed: 23970633
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21649
pubmed: 28770595
Patient Prefer Adherence. 2016 Jul 11;10:1197-203
pubmed: 27468229
Perm J. 2020 Dec;24:1-3
pubmed: 33482953
PLoS Med. 2018 Aug 13;15(8):e1002636
pubmed: 30102693
BMC Infect Dis. 2017 Dec 13;17(1):766
pubmed: 29237401
AIDS Care. 2018 Dec;30(12):1477-1487
pubmed: 30037312
Int J Environ Res Public Health. 2021 Mar 03;18(5):
pubmed: 33802322
J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):540-546
pubmed: 31021988

Auteurs

Raphael Onyango Mando (RO)

Research Care and Training Program, Center for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.

Michelle Moghadassi (M)

Department of Gynecology, Obstetrics, and Reproductive Sciences, University of California San Francisco, California, United States of America.

Eric Juma (E)

Research Care and Training Program, Center for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.

Cirilus Ogollah (C)

Research Care and Training Program, Center for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.

Laura Packel (L)

The University of California Berkeley, Berkeley, California, United States of America.

Jayne Lewis Kulzer (JL)

Department of Gynecology, Obstetrics, and Reproductive Sciences, University of California San Francisco, California, United States of America.
The University of California Berkeley, Berkeley, California, United States of America.

Julie Kadima (J)

Research Care and Training Program, Center for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.

Francesca Odhiambo (F)

Research Care and Training Program, Center for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.

Ingrid Eshun-Wilson (I)

Division of Infectious Diseases, Department of Internal Medicine, Washington University in St. Louis, St. Louis, Missouri, United States of America.

Hae-Young Kim (HY)

School of Medicine, New York University, New York, New York, United States of America.

Craig R Cohen (CR)

Department of Gynecology, Obstetrics, and Reproductive Sciences, University of California San Francisco, California, United States of America.

Elizabeth A Bukusi (EA)

Research Care and Training Program, Center for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Department of Gynecology, Obstetrics, and Reproductive Sciences, University of California San Francisco, California, United States of America.
The University of California Berkeley, Berkeley, California, United States of America.

Elvin Geng (E)

Division of Infectious Diseases, Department of Internal Medicine, Washington University in St. Louis, St. Louis, Missouri, United States of America.

Classifications MeSH